Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood test
MedTech
Exact Sciences rolls out Cancerguard multi-cancer blood test
Priced at $689, Cancerguard will open up to broad consumer access through its own telehealth portal next month.
Conor Hale
Sep 11, 2025 1:00pm
Roche nets EU approval for blood test to rule out Alzheimer's
Jul 25, 2025 11:00am
Quest to carry Fujirebio’s FDA-cleared Alzheimer’s blood test
Jul 11, 2025 11:40am
Grail plans to submit updated Galleri blood test to FDA in 2026
Jun 18, 2025 11:45am
Quest Diagnostics taps MD Anderson for cancer risk blood test
Jun 10, 2025 2:11pm
FDA clears its first blood test for diagnosing Alzheimer's
May 16, 2025 4:30pm
